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It is a well established fact that killed tubercle bacilli can be used to increase 
the resistance of laboratory animals to experimental tuberculosis. Among the 
earlier experiments  those of Opie and  Freund  (1)  stand  out.  These  workers 
conspicuously elevated the relative resistance of rabbits by repeated injection 
of heat-killed  tubercle bacilli.  Among many other authors,  Dubos, Schaefer, 
and Pierce (2) later demonstrated in mice the immunogenic  efficacy of single 
doses of phenol-killed tubercle bacilli. 
It is reasonable to expect, therefore,  that  certain  substances derived from 
tubercle bacilli  by chemical  means  would  be active in promoting  increased 
resistance  to  experimental  tuberculosis.  Crowle  (3),  in a  recent review,  has 
summarized the attempts of many authors during the recent decades to impli- 
cate the proteins and polysaccharides of culture filtrates, the "waxes," phospha- 
tides and lipopolysaccharides of the cell bodies, and  combinations  of these in 
the immunogenic capacity of the killed tubercle bacillus. The experiments with 
antigone m2thylique of N~gre and Boquet (4), N~gre (5), and N~gre and Bretey 
(6) were the most promising of such efforts. The enhanced resistance,  elicited in 
rabbits and guinea pigs by these workers, was observed in mice by Weiss and 
Dubos (7, 8) following a  single injection of a  similar  material  extracted from 
phenol-killed  tubercle bacilli by methanol  at  55°C.  The methanol  extract of 
Weiss and Dubos was less toxic in immunogenic doses than whole killed tubercle 
bacilli,  though  no more protective on a  weight for weight basis.  The  use of 
adjuvants such as typhoid polysaccharide, however, increased the level of the 
protective effect. 
The object of the present study is the purification and characterization of the 
active substance or substances of methanol  extract.  In this respect it is our 
purpose to describe the preparation of fractions and subfractions of methanol 
extracts of virulent tubercle bacilli  (strain H37Rv), and to present experiments 
demonstrating the value of certain of these preparations when used as chemi- 
cally derived vaccines. The experiments reported were performed in 1957 and 
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FIG.  1.  Diagram of constant  temperature,  continuous  extraction apparatus. 
A, distilling flask, 2,000 ml.; T  29/42 outer joint, center; fiat ground platform joint side 
(c).* 
B,  Friedieh reflex condenser with  T  29/42  inner joint. 
C,  distillate collector, column  insert with  sealed-in funnel.  T  29/42  top  and  bottom, 
ball joint on collecting tube shunt. 
D,  jacketed  connecting  tube.  (Liebig condenser with ball and  socket joints.) 
E,  8  inch insertion thermometer  with  T  inner joint. 
F,  jacketed extractor for 180  X  60 ram. thimbles (c). 
G,  syphon-loop connector with ball and  socket joints  (c). 
H,  delivery tube adaptor with socket joint,  top,  and  flat ground  joint,  bottom  (c). 
* (c)  indicates  custom  made  items  according  to  author's  specifications. C. A. WILLIAMS~ JR.~ AND R. J.  DUBOS  983 
early 1958. Their publication was delayed until the preparative procedures had 
been repeated  and  standardized  and until  the biological properties  of the new 
products  had  been determined. 
Materials and Metkods 
Preparation  of  Vaccines: 
The  "tubercle bacilli germ mass  (vacuum-dried)  X-0482,  Lot A  and  Lot B," used  for 
the extraction of the materials to be described in this report was obtained from the research 
department of Parke, Davis & Co. through the generosity of R. W.  Sarber. Mycobacterium 
tuberculosis var. hominis (H37Rv)  had  been  grown  on  Lung's  synthetic  medium  for  ap- 
proximately 3 months. The cultures were killed by a 3 hour treatment in flowing steam and 
then filtered. Lot A  (May,  1956) was held without preservative and vacuum-dried, yielding 
165 gin.  dry weight. Lot B  (November,  1950) was stored under 0.5 per cent phenol until 
June,  1956. At this time it was filtered and  vacuum-dried, yielding 1095 gin.  dry weight. 
Upon receipt at this laboratory, Lots A  and B  were pooled and pulverized by blending at 
high speed with acetone chilled to below  -50°C.  The acetone powder was collected on a 
Buehner funnel, rinsed with anhydrous diethyl ether, and dried in a  vacuum oven at 50°C. 
Preparation and Fractionation  of Extracts from Tubercle Bacilli.--An appara- 
tus was designed capable of continuously extracting 100 gm. or more dry germ 
mass at carefully controlled temperatures.  As seen in Fig. 1, the apparatus  is a 
modified  Soxhlet extractor  in  which  the  extraction  chamber  has  been  placed 
outside the distilling column. 
The condensate is conducted  to the extraction chamber by means of the distillate col- 
lector in the section below the condenser.  The temperature  of the extraction is controlled 
in two ways.  First,  the connecting tube from the distillate collector is jacketed so that it 
may be cooled or heated as desired.  It is particularly important that the condensate coming 
from the distilling column to the extraction chamber be maintained  at a  fairly high tem- 
perature ff the extraction is to be effected at a  temperature significantly above room tem- 
perature, or cooled if to be carried out many degrees below the boiling point of the solvent. 
Second,  the extraction chamber  itself is jacketed with a  relatively large volume of water 
circulated  by  a  water  bath.  It  was  found  that  while  this  latter  jacket  will  maintain 
a  high  temperature  fairly  well,  it  is not  sufficient  to  adjust  the  extraction  temperature 
to a  relatively low level before the chamber automatically empties. The center of the large 
germ mass contained in the asbestos  thimble  (180  X  60 mm.)  would remain close to the 
boiling point of the arriving solvent were the desired extraction temperature not approxi- 
mated during the passage of the solvent through the shunt from the distilling column. With 
a  more efficient  temperature control in the shunt,  it would be quite possible to limit fluc- 
tuation of the extraction temperature to a  fraction of a  degree Centigrade. The apparatus 
as  illustrated  here permitted  fluctuations within a  3  to 4  degree range. 
It has been found that extraction at temperatures at least as high as 55°C.,  as initiated 
by Weiss and Dubos (7) are necessary to remove from the germ mass all the methanol-soluble 
substance which increases the resistance of mice to experimental tuberculosis. The antigone 
m~thylique of N~gre and coworkers was extracted at 37°C.  Fractional extraction of the germ 
mass by methanol at 40°C.  prior  to an extraction at 60°C.  provided a  material  (ME-40  °) 
roughly equivalent to antigone mgthyligue, and another (ME-60°), presumed to contain what- 984  METHANOL EXTRACTS OF TUBERCLE BACILLI.  I 
ever supplementary activity is extractable at higher temperature. From 100 gin. of H37Rv, 
9.2 gm. was removed by acetone, 10.8 gin. by methanol at 40  ° in 72 hours, 2.6 gin. by methanol 
at 60  ° in 72 hours. Continued extraction with methanol at 60  ° for 5 more days yielded 0.6 gin. 
more,  and another 5  days  but  another 0.3  gin. 
Fractional extraction was abandoned as a  purification technique. 
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FIo.  2.  Flow sheet for the extraction and fractionation of methanol extract of tubercle 
bacilli (H37Rv). 
A typical flow sheet for the extraction and crude fractionation of the methanol 
extract (ME) is presented in Fig. 2.1 
The germ mass (generally 100 gm.)  is extracted with acetone at 36-40°C.  for 48 hours. 
Between 9 and 10 per cent of the dry weight is removed by this "defatting" procedure. After 
washing the residue with cold methanol and allowing it  to  drain several times,  methanol 
is added to the distilling flask and the extraction temperature is adjusted to 58-60°C. After 
1 All solvents used in these preparations were Merck reagents. Technical grade  methanol 
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48 hours  ME,  presumably  including the antigdne m~thylique of  N~gre and  Boquet,  is re- 
moved. Another 10 per cent or more of the dry weight of the starting material is found in 
in this extract. 
Upon cooling there is a  general precipitation of material soluble in warm methanol. In 
an effort to  control this to  advantage,  the methanol extract  (approximately  1000  ml.)  is 
placed in a  vacuum flask and maintained between 45  ° and 50  ° by means of an electric hot- 
plate while a jet of air induced by vacuum is directed on the surface of the solution. In this 
fashion,  the volume of  the  extract is slowly reduced  until the various components reach 
their  critical  concentration for  this temperature.  The  first  fraction  to  precipitate  out  of 
solution is characterized by light white floccules in the first stages. Later when the volume 
has been reduced to between 200 and 300 ml. it becomes heavier and sticky, being contami- 
nated with the second  distinct fraction, which is a  soft, yellow,  wax-like substance. This 
latter material is collected separately between 250 and 50 ml. volume. Below that point it 
becomes heavily contaminated with inorganic salts  (FIII)  and  residue  products  soluble 
in cold methanol (F IV). F IV contains highly pigmented materials. Only the first two frac- 
tions, F  I  and F  II, have been refined. 
Both F I and F II can be pulverized and washed relatively free of the pigmented material 
characteristic of F  IV in ice-cold methanol, and collected on a  small Buctmer funnel. They 
are  then removed  to  an  acetone slurry,  which maintained at  a  low  temperature permits 
further hardening, pulverization, and removal of fatty materials. It must be stated, how- 
ever, that aside from a  very small amount of yellowish residue, the fractions appear to be 
insoluble in acetone at even higher temperatures. Acetone, therefore, is used to replac~ all 
other organic solvents associated with the preparations of F  I  and F  II, and is used very 
effectively as a  drying agent. 
The major component of F  I is insoluble in petroleum ether [30-60  °] and petroleum ether 
[60-70  °  ]  although  slightly  soluble  and  extractable  by  petroleum  ether  [90-100  °  ]  whereas 
F  II is very soluble in this solvent.  ~ Thus three washings of crude F  I  with petroleum ether 
[30-60  °] suffices  to remove any gross contamination of F  II; and similarly, dissolving crude 
F  II leaves a fine white residue of F  I  and F  III contaminants. Petroleum ether is removed 
from both fractions by acetone washes, although F  II must be evaporated to near dryness 
and repulverized in acetone. 
Subfractionation.--F  I  can  be  subfractionated  in  several  ways.  However, 
Methods A and B, illustrated in Fig. 3, appear to be the most reproducible. 
Method A  was suggested by the fact that some lipopolysaccharides are slightly soluble 
in ethanolic salt solutions. Ethanol is added to a  water suspension of F  I  until the solution 
is 33 per cent ethanol by volume. F I is noticeably more soluble in this mixture than in distilled 
water, but the addition of sodium chloride to 0.5 per cent of  total alcoholic volume muses 
the precipitation of 90 per cent or more of the total fraction. For the experiments reported 
below, the precipitate was  resuspended in water and reprecipitated in the same manner a 
second time.  It accounted  for 46 mg. of  an original 50 mg., a  typical  sample size,  carried 
through the  subfractionation procedure.  The supernatant solution was  evaporated over a 
hot-plate to  remove ethanol. 
2 A simple test indicated that unless F I, F II, and the petroleum ether are scrupulously 
dry, F I  may be extracted into solution. One drop of water in 100 ml. of petroleum ether is 
sufficient to ruin the separation. Recent studies indicate that purified hydrocarbons such as 
methylpentane and  n-hexane might better distinguish between  F I  and  F II.  The  cyclic 
hydrocarbons are less satisfactory in this regard, thus a petroleum ether cut rich in such com- 
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Method B  depends on the fact that approximately 80 per cent of the fraction is precipi- 
tated from the hot methanolic solution by the dropwise addition of cupric acetate in methanol. 
This is apparently a  stoichiometric combination of the copper with some chemical grouping 
associated with this class of  compound.  3 Precipitation  occurs up  to  a  certain point with 
l 
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Add H~O and repeat 
Precipitate 
2 X  and  re.suspend, 
dialyze. FI-P 
METHOD A 
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repeat 
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Evaporate ethanol. FI-S 
METHOD B 
MeOH solution FI 
(5 to 10 mg./ml., 55°C.) 
+ 
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Wash 2 ×  Supernatant 
+  + 
H~S  "H~S 
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Add  H~O  and  evaporate  Add  H~O  and  evaporate 
MeOH, dialyze. ~I-CP  MeOH, dialyse. FI-CS 
Fro.  3.  Subfractionation of FI  (See Fig.  4)  by ethanol and sodium chloride from water 
suspension, Method A;  and  by  cupric  acetate from  methanol solution,  Method  B. 
absolutely no  hydrogen  sulfide-detectable copper  in  solution.  Only when no  further  pre- 
cipitation occurs will the blue color appear in the supernatant. The precipitate can be solu- 
a Several divalent metal ions were tried in the search for a  precipitant for a  fraction of 
methanol extract.  Among lead,  mercury,  iron,  calcium,  barium,  and  copper,  only copper 
seemed effective and manageable without special attention to pH and temperature. Barium 
also complexed methanol extract substance but lacking color in solution did not seem as con- 
venient as copper.  Pangborn (9)  has mentioned the use of barium in the purification of a 
phosphatide from tubercle bacilli as a  barium salt. C.  A. WILLIAMS,  JR., AND R. J. DUBOS  987 
bilized with Naeethylene-diaminetetraacetic acid (versene), but removal of the copper from 
both supernatant and precipitate is most eadly effected by bubbling hydrogen sulfide through 
the methanol suspension. The resulting methanol solutions are pipetted to an equal volume 
of warm water, evaporated over a  hot-plate to remove most of the methanol and hydrogen 
sulfide, then dialyzed against water. During this procedure, it is imperative that all methanol 
solutions be maintained above 55°C.  in order to avoid spontaneous predpitation of a  part 
or all of the fraction. 
All dialyses were performed with Visking cellophane tubing No.  18/32.  This tubing is 
impermeable to substances of molecular weight 6,000 as determined by dialysis studies with 
insulin (9, 10). 
Properties.--The  physical and chemical properties  of the fractions described 
above will be reported in further detail in a later publication.  No attempt will 
be made at this time to relate these substances  to the waxes, soft waxes, phos- 
phatides, and/or lipopolysaccharides  described  by other authors. One of the 
most interesting subfractions,  the supernatant (FI-S) from the treatment of F I 
with ethanol and sodium chloride (Method A), has not to date been analyzed 
because it has been available in such limited quantities. 
Fractions F I and F II both contain less than 0.2 per cent Kjeldahl nitrogen. 
Certain preparations of F I have contained less than 0.1 per cent N. Both frac- 
tions contain phosphorus,  but depending upon the preparation the content will 
vary from 1.7 per cent to 2.4 per cent by the standard Fiske-Subarrow titration 
as described by Kabat and Mayer (11). F I and F II are both Molisch-positive 
although F I is much the stronger in this regard.  In F I  this property is con- 
fined to that moiety precipitable  by ethanol and sodium chloride (FI-P), which 
gives a bright red-violet reaction. FI-S, concentrated for the test, gives a faint 
brownish color. The F  II reaction color is more violet than red.  Semiquantita- 
tive Molisch tests (11), by comparison  with known amounts of reducing sugars 
such  as  glucose,  galactose,  or  mannose,  indicate  that  a  large  portion  of 
FI-P is carbohydrate, perhaps  as much as half. 
Experimental  Ma2erials: 
My,obaaeriura  ~ubemulosis  var.  bo~/s  (Vall~e)  MV was  used  to  challenge mice.  In  all 
experiments described below, the bacteria were grown on Dubos-Middlebrook liquid medium 
for surface growth for 10 days at 37°C.  (12). The pellicle germ mass was harvested by skim- 
ruing the surface with a  spatula, pressed dry on absorbent filter papers, and weighed into 
a  grinding tube. A  suspension suitable for intravenous injection in mice was prepared by 
dispersing the germ mass in 0.2 per cent tween 80 in physiological saline with a teflon grinder. 
This was appropriately diluted in tween-saline to deliver 0.1 rag. paper-dry tubercle bacilli 
per mouse in 0.2 ml. 
Micrococcus pyogenes  var. aureus  (Giorgio)  (13)  for staphylococcal challenge was grown 
18 hours in tryptone broth at 37°C.  For intravenous injection 0.05 ml. of this culture was 
delivered to  each mouse in a  total volume  of  0.2  nil. 
Animals.--Rockefeller  Swiss  albino  male  mice  were  used  throughout  the  study.  The 
animals were received shortly after weaning at an age of approximately 4 weeks and were 
randomized into groups  of  5  or  6  depending on the requirements of the experiment.  The 
mice were maintained in metal boxes, fed antibiotlc-free pellets (Rockland mouse diet, Rock- 988  METHANOL EXTRACTS  OF TUBERCLE BACILLI.  I 
land Farms, New York), and were provided with water ad lib. During the 1st week they re- 
ceived 3 per cent terramycin in their drinking water (of. Dubos and Schaedler, reference 14, 
page 705).  Mter being infected with tubercle bacilli, mice were removed to isolated quarters 
and housed two to a cage. 
Statistical Methods: 
Tabulation  of Data  in  "A"  Tables.--All  data obtained from  survival experiments with 
mice are tabulated in vertical columns as individual survival times expressed in days fol- 
lowing challenge.  Extreme data have been rejected with 90 per cent confidence or greater 
according to the Q test  (15).* High  values have been rejected with 95 per cent confidence 
or better. These are represented by R  followed by the value obtained in parentheses. 
When a  group  was  deficient in  number of  animals an  objectively appropriate  liberty 
has been taken in the placement of blanks (--) in the column of data.  The first such de- 
ficiency was placed in the first or last position, whichever shifted the column so as most 
to approximate the pattern established by the control group. Thus any shortage of data was 
consistently used to minimize the apparent experimental etficacy of a  vaccine preparation. 
The second blank, if any, was recorded in the middle of the column following the first half 
of the group.  These measures permitted comparison of all the groups at various points in 
the course of  the experiment by scanning the tables horizontally. This is essential to  the 
understanding and  significance of  B  tables. 
Survivors, at the time the experiment was terminated,  are represented in the table by 
S.  For the statistical analysis these had to be disregarded as no justifiable value could be 
assigned to them. The analysis of data in Table I A includes only the first ten survival times 
in each group. No analysis of Table IV A was attempted. Probability values were obtained 
from  calculations of  Student's t  according to  Hod  (16). 
B  Tables, Cumulative Average Survival  Times.--Each survival time in order of occurrence 
of death is averaged with all the preceding survival times within its group.  Such a  set of 
figures for any one group is suitable for plotting graphically the state of resistance or sus- 
ceptibility of the group to the imposed infection. The curves obtained are relatively smooth 
compared to what would be expected from a plot of the primary data; but the slope of any 
given curve is related to the variability and range of the primary data.  If time is plotted 
along the ordinate, the elevation of the curve is an expression of the resistance or  suscepti- 
bility achieved by the experimental treatment. This method of handling data for the visuali- 
zation of  group  response in  survival experiments has been introduced by Riley  (17,  18). 
4 A  questionable value in a  small number of observations may be rejected with 90  per 
cent confidence if Q0.90 exceeds  the  value in  the  table for a  given number of observations, 
n, Q  being determined by the formula, 
Q  =  (x,,  -  x._,)/w 
in which x, is the questionable value, x,_l its nearest neighbor, and w the range including x, • 
6 
10 
11 
12 
0o.,o 
0.56 
0.41 
0.39 
0.38 
0.71 
0.51 
0.48 
0.45 
O0.~ values are (estimated from progres- 
sion of Student's t, for 0.05 prob- 
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A value for the mean cumulative  average (MCA) was calculated from four successive cumu- 
lative averages in the middle of the set. Although this number is not the true mean of the 
set, it is close to the true mean when the set of values is complete. In the middle region of 
the set or the curve, while the values take into account the early deaths, the slope will have 
recovered  from their effect even though moderately extreme.  Although there were very few 
survivors in the present studies with experimental tuberculosis,  there were not infrequently 
some  rather late deaths which do not correlate with any known  experimental condition. 
With staphylococcus infections  there were not only late deaths, but there were more sur- 
vivors, the latter being very difficult to deal with when the data are desired in terms of time 
of death. The mean cumulative  average virtually eliminates the effect of extraordinarily late 
deaths and survivors. Thus, the contribution of extreme data could not lead to an impression 
of increased resistance. 5 
An index  oJ resistance  (IR)  provides a  satisfactory means  for the comparison  of group 
response from experiment to experiment.  This index is nothing more than the quotient of 
the mean cumulative  average from an experimental group of animals divided by the mean 
cumulative  a~erage for the control group.  Thus, the control group is arbitrarily assigned an 
IR  =  1. The decimal fraction in excess of 1 multiplied by 100 gives the per cent increase 
in mean cumulative average survival time afforded  by the treatment. 
EXPERIMENTS AND  RESULTS 
1.  In Tables I  A and I  B  are recorded the data from an experiment designed 
to test the relative effectiveness of subfractions of F  I used as vaccine to increase 
the resistance of mice to tuberculosis. Vaccination consisted of a  single intra- 
peritoneal injection of 1 mg. of F  I  in 0.2 ml. water, or that amount of the sub- 
fraction derived from 1 rag. of F  I. Thus approximately 0.9 mg. of FI-P and 0.1 
mg.  of FI-S were used; 0.2 mg.  FI-CS and 0.8 mg.  of FI-CP. The mice were 
challenged intravenously with 0.! mg.  (wet weight) of pellicle gown  M. tuber- 
culosis,  strain Vall~e, (MV) 47 days after vaccination; i.e. roughly 7 weeks. 
Examination of the data and the plotted curves  (Fig. 4)  of the cumulative 
average  survival  times  suggests  that,  while  F  I  offers  slight  protection,  its 
subfractions are more promising. Most notable are the supernatants of either 
the  ethanol-NaC1  method  or  the  cupric acetate  method.  Indeed the  indexes 
of resislance indicate that mice vaccinated with FI-S or FI-CS could be expected 
to survive respectively 40 per cent and 30 per cent longer than controls injected 
with water. The precipitates, FI-P and Cu-P,  outperform the parent fraction 
F  I  by  insignificant margins.  The  experiment  further  suggests  some  sort  of 
non-active form of FI-S or FLCS in the total F  I  fraction. 
2.  Another vaccination experiment was designed to compare the effectiveness 
of admixtures of F  II and F  I  with F  I  subfractions. The results are shown in 
Tables  II A  and  II  B,  and  the  cumulative averages  of  selected groups  are 
plotted in Fig. 5.  The  interesting facts revealed by this experiment are that, 
while 0.1 mg. of F  I  is shown to be of little value,  and 1.0 rag. of F  II to have 
5 For this purpose Riley uses the average survival time of the first 50 per cent of the ani- 
mals to die, or the median  cumulative  average. TABLE I A 
Resistance to M. tuberculosis Infection:* Individual Survival  Time--(Days) 
Order of 
death 
7 
8 
9 
10 
11 
12 
Vaccination  preparation$ 
Water 
9 
11 
12 
13 
13 
14 
14 
14 
15 
18 
R(39) 
S 
FI 
lmg. 
12 
13 
14 
14 
16 
16 
17 
18 
19 
19 
20 
22 
FI-P  FI-S 
~..~0.9  rag.  ~0.1  rag. 
R(4)§  13 
13  14 
14  18 
15  19 
16  20 
17  21 
--  22 
17  24 
22  24 
24  28 
R(53)  35 
S  35 
17.25  20.3 
2.67  4.26 
0.04  0.004 
CuP 
~0.8  rag. 
9 
12 
13 
14 
16 
21 
22 
22 
24 
28 
S 
S 
Cu-S 
,',,0.2  tug. 
13 
14 
14 
17 
20 
21 
22 
22 
24 
28 
31 
R(45) 
:~[] .........  13.3  15.8  18.1  19.5 
t ...........  --  2.28  2.29  3.58 
P ..........  0.05  0.05  0.008 
TABLE I B 
Resistance to M. tuberculosis Infection:* Cumulative Average SutUral Time 
Vaccination  preparations 
Order of 
death  FI  FI-P  FI-S  Cu-P  Cu-S 
Water  1 mg.  ~0.9 mg.  ~0.I rag.  ,','0.8 rag.  N0.2 rag. 
9 
10 
I1 
12 
MCA ....... 
IR ......... 
9.0 
10.0 
10.7 
11.2 
11.6 
12.0 
12.3 
12.5 
12.8 
13.3 
R 
S 
12.8 
1.0 
12.0 
12.5 
13.0 
13.25 
13.8 
14.2 
14.6 
15.0 
15.5 
15.8 
16.2 
16.7 
14.4 
1.12 
R§ 
13.0 
13.5 
14.0 
14.5 
15.0 
15.3 
16.3 
17.2 
R 
S 
14.9 
1.16 
13.0 
13.5 
15.0 
16.0 
17.0 
17.5 
18.0 
19.0 
19.5 
20.3 
21.6 
22.75 
17.9 
1.40 
9.0 
10.5 
11.3 
12.0 
12.8 
14.2 
15.3 
16.1 
17.0 
18.1 
S 
S 
L 
14.6 
1.14 
13.0 
13.5 
13.7 
14.5 
15.6 
16.5 
17.3 
18.0 
18.6 
19.5 
20.5 
R 
16.9 
1.32 
* Mice challenged intravenously 0.1  mg.  (wet weight) Vall6e  MV in 0.2  ml. saline, 0.05 
per cent tween 47  days after vaccination. 
Mice vaccinated intraperitoneally with 0.2 nil.  of distilled water suspensions. 
§ R, rejected value not used in statistical analysis. Actual survival time in parentheses. 
I[ Statistical analysis includes only first 10 data in each group. 
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low grade activity at best, mixtures of these two fractions are remarkably active. 
Where F  I  and F  II are combined in equal amounts, even where the total dry 
weight of the mixture administered to each mouse is but 0.1 rag., survival time 
is increased nearly 70 per cent. A  total vaccination dose of 1.0 mg. lengthens 
survival time approximately 80 per  cent. Since these are considered important 
observations,  it is  worth mentioning  that  this  pattern  has  been  repeated  in 
subsequent experiments, although the IR values were not of the same order. 
25 
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NUMBER  MICE  DEAD  AND  AVERAGED 
FIG. 4. The increase in cumulative  average survival  time of mice infected with virulent 
tubercle  bacilli (Vall~e MV) following vaccination  with 1 rag. fraction  FI of methanol  ex- 
tract  (M),  0.1  rag. of subfraction  FI-S  (/x).  Water vaccinated  controls  (O). 
As each successive animal  succumbed to the infection, its survival  time  was averaged 
with  those of the preceding victims  of its group.  Each point represents  the new average 
survival time at the time of death of the number mice indicated  on the abscissa. The slope 
of the curve relates to the variability  and range within the group. The level on the vertical 
axis expresses the increase in resistance  to the infection. 
Except that the time elapsed between vaccination and challenge was 39 days, 
all known conditions were the same for this experiment as those in the experi- 
ment above. Nonetheless all groups survived more than twice the  time as those 
previously discussed. This is possibly attributable  to a variation in the state of 
the  challenge organisms.  With  the  across-the-board extension  of the survival 
times,  the index of resistance seems to increase also. Thus, the group receiving 
FI-S as vaccine resists 47 per cent longer than  the controls even though they 
received  only half the  quantity of vaccine required  to give them 40 per cent TABLE II A 
Resistance to M. tuberculosis Infection:* Individual Survival Time--(Days) 
Vaccination preparation~t 
Order of 
death 
Water 
6 
7 
8 
9 
10 
P. 
18 
22 
27 
I  32 
36 
43 
46 
49 
49 
63 
38.5 
FI 
0.1 nag. 
14 
26 
26 
29 
44 
46 
50 
56 
58 
59 
40.8 
0.34 
0.76 
FLI 
1.0 mg. 
14 
27 
34 
36 
44 
48 
50 
52 
53 
70 
42.8 
0.65 
0.54 
FI +  FII  FI +  FII 
1.0 mg.  0.1 mg, 
--§  39 
45  44 
47  46 
52  50 
53  53 
63  54 
63  56 
63  56 
64  57 
65  60 
57.1  51.5 
3.52  2.64 
0.01  0.03 
FLP 
,.,,0.4 mg. 
27 
28 
38 
42 
42 
48 
50 
51 
64 
74 
46.4 
1.23 
0.25 
FI-S 
~0.05 rag. 
25 
39 
42 
46 
49 
51 
52 
58 
67 
70 
49.9 
1.87 
0.10 
TABLE  II B 
Resistance to M. tuberculosis Infection:* Cumulative Mean Survival Time 
Vaccination preparations 
Order oi 
death  Water  FI-P  FI-S  0.4 rag.  0.05|rag. 
8 
9 
10 
MCA ......... 
IR ........... 
18.0 
20.0 
22.3 
24.7 
27.0 
29.7 
32.0 
34.0  38.1 
35.8  I  38,8  39.8 
38.5  40,8  42.8 
278  ]29  132.1 
1.011.0411.15 
0.1 rag.  1.0 nag.  1.0 rag.  0.1 rag. 
14.0114.0[--§  39.0[27.0 
20.0  J  20.5  I  45.0  41.5  I  27.5 
22.0  25.0  46.0  43.0  ]  31.0 
23.7  27.7  48.0  44.7  33.7 
27.8  31.0  49.2  46.4  35.4 
30.8  33.8  52.0  47.7  37.5 
33.6  36.1  53.8  48.9  39.3 
36.4  55.0  49.7  40.75 
56.2  [  50.6  43.33 
57.2  51.5  46.4 
50.7  [  46.9  36.5 
1.82  j  1.69  1.31 
25.0 
32.0 
35.3 
38.0 
40.2 
42.0 
43.4 
45.25 
47.7 
~.9 
40.9 
1.47 
* Mice challenged intravenously 0.1 mg.  (wet weight) Vail& MV in 0.2 ml. saline, 0.05 
per cent tween 39 days after vaccination. 
Mice vaccinated intraperitoneally with 0.2 ral. of distilled water suspensions. 
§ Group deficient in numbers. See explanation in text. 
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advantage in the previous experiment. The same relationship holds for FI-P, 
which for the purposes of comparison can be considered equivalent or slightly 
better than total F  I  in resistance-enhancing capacity. 
3.  An experiment was undertaken in an attempt to establish the time which 
must elapse following vaccination with F I before mice show increased resistance 
to  tuberculosis.  Sixty mice were  randomized into  groups  of five and  main- 
tained under identical conditions for 12 weeks before the proposed challenge date. 
6O 
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Fro. 5. The increase in cumulative average survival time of mice infected with virulent 
tubercle bacilli (Vatlc~e  MV) following  vaccination with I rag. FII (0), 0.05 rag. FI-S (A) 
(of. Fig. 4), 0.5 rag. FI plus 0.5 rag. FII (A). Water vaccinated controls (O)  (see Table 
II B). 
For explanation of graph  see legend for  Fig.  4. 
During this period, groups of ten were vaccinated at intervals so that by the 
challenge date there would be a  group of ten mice representing each of five 
vaccination periods, 1, 2, 4, 8, and 12 weeks. Ten mice were injected with water 
12 weeks before challenge. The same F  I  suspension was used to vaccinate all 
groups.  The results presented in Tables IIIA  and  III B  demonstrate  that 
resistance is high at 2 weeks following vaccination with F I, but that at 4 weeks, 
virtually all advantage over the controls had been lost. However, mice vacci- 
nated 8 and 12 weeks before challenge, did show a significantly high IR. 
4.  Of considerable interest is the high IR at 2 weeks. Studies by Dubos and 
coworkers (14, 28, 29) which were in course at the time these experhnents were 
being performed, suggested the possibility that heightened levels of resistance to 994  METHANOL EXTRACTS OF TUBERCLE BACILLI.  I 
TABLE YII A 
Resistance to M. tuberculosis Infection:* Individual Survival  Time--(Days) 
Order of death 
6 
7 
8 
9 
10 
£ ........... 
t ............ 
P ........... 
Vaccination period (wks.)J; 
Water 
(12) 
21 
24 
31 
34 
34 
34 
38 
38 
42 
48 
34.4 
22 
31 
34 
34 
38 
48 
48 
53 
56 
70 
43.4 
1.75 
0.12 
29 
34 
35 
45 
48 
48 
51 
51 
61 
62 
46.4 
2.79 
0.02 
21 
24 
30 
38 
41 
41 
42 
48 
49 
51 
38.5 
0.99 
0.36 
21 
41 
42 
43 
48 
48 
50 
50 
42.9 
2.06 
0.085 
12 
28 
31 
41 
42 
43 
43 
43 
48 
48 
51 
42.8 
2.63 
0.03 
TABLE HI B 
Resistance to M. tuberculosis  Infection:* Cumulative Average Survival Time 
Order of death 
8 
9 
10 
MCA ....... 
IR ......... 
Water 
(12) 
21.0 
22.5 
25.3 
27.5 
28.8 
29.7 
30.9 
31.75 
32.9 
34.4 
29.2 
1.00 
22.0 
26.5 
28.8 
30.2 
31.8 
34.5 
36.4 
37.5 
40.4 
43.4 
33.2 
1.14 
Vaccination period  (wks.)$ 
2  4 
29.0  21.0 
31.5  22.5 
32.7  25.0 
35.75  29.5 
38.2  31.0 
39,8  32.5 
41.4  33.9 
42.6  35.6 
44.7  37.0 
46.4  38.5 
38.8  31.7 
1.33  1.08 
21.0 
31.0 
34,7 
36.75 
39.0 
40.5 
41.9 
42.9 
37.7 
1.29 
12 
28.0 
34.5 
36.7 
38.0 
39.0 
39.7 
40.1 
41.1 
41.9 
42.8 
38.2 
1.31 
* Mice challenged intravenously 0.1 mg. (wet weight) 
Tween. 
Mice vaccinated intraperitoneally with 1 mg. FI in 
Vall6e  MV in 0.2 ml. saline, 0.05% 
0.2 ml. distilled water. C. A. WILLIAMS~ J~.~ AND R. J. DUBOS 
TABLE IV A 
Resistance to Staphylococcus (C-iorgio) Infection:*  Indivldual Survival  Time--(Days) 
995 
Vaccination period (wks.)~ 
Order of death 
Water  1  2  4  8  12  (12) 
§ 
6 
7 
8 
9 
10 
3 
4 
5 
6 
12 
S 
S 
S 
2 
4 
4 
6 
7 
12 
S 
S 
3 
4 
4 
4 
5 
S 
S 
S 
S 
TABLE IV B 
Resistance to Staphylococcus (Giorgio) Infection:*  Cumulative Average Sun~ival Time 
Vaccination period (wks.)~/ 
Order of death 
Water  (12)  1  2  4  8  12 
§ 
8 
9 
10 
2.0 
2.0 
2.7 
3.0 
3.2 
3.5 
3.7 
3.9 
4.3 
S 
2.0 
2.5 
2.7 
3.0 
3.5 
4.2 
4.6 
3.0 
3.5 
4.0 
4.5 
6.0 
2.0 
3.0 
3.3 
4.0 
4.6 
5.8 
S 
S 
3.0 
3.5 
3.7 
3.75 
4.0 
S 
MCA .......  3.3  3.8  4.8  4.0  3.8 
IR ........  1.00  1.15  1.45  1.21  1.15 
* Mice challenged intravenously with 0.05 ml. of 18 hour broth culture diluted with 0.15 
mL saline. 
:~ Mice vaccinated intraperitoneally with 1 rag. FI in 0.2 ml. distilled water. 
§ Data for the 8 week period not reported owing to disparity of behavior in the two sub- 
groups of five mice. 996  METHANOL EXTRACTS  OF TUBERCLE BACILLI.  I 
tuberculosis might be an expression of a non-specific increase in the activity of 
the general defenses of the mouse. The fact that methanol extract was of myco- 
bacterial  origin,  and  that  resistance  to  tuberculosis  was  increased,  may be 
coincidental and need not imply immunological specificity. To examine this 
possibility, sixty mice from the same weaning as those used for Experiment 3, 
randomized and cared for in the same way, and vaccinated at the same time 
with the same suspension of F I, were challenged with staphylococcus (Giorgio). 
The results in Tables IV A and IV B show that there is indeed a considerable 
increase in resistance to staphylococcus infection at 2 weeks, which falls off to a 
lower level by 4 weeks,  e The number of survivors in the 12 week group makes 
the group difficult to evaluate numerically. However, if survivorship has any 
1.5 
1.4 
1.3 
IR 
1.2 
I.I 
I.Oc  I  I  |  I  I 
I  2  4  8  12 
VAGCINATION  PERIOD (WEEKS) 
FIO. 6. Variation of index of resistance (IR) with respect to length of vaccination period. 
All mice received 1 rag. FI except the controls (C)  which received 0.2 ml. water  12 weeks 
before challenge. Infection with tubercle bacilli (ValMe MV)  (1"1). Infection with staphylo- 
coccus (Giorgio)  (1)- See Tables III B  and IV B. 
meaning in experiments of this nature, resistance at 12 weeks post vaccination 
should be at least as high as at 4 weeks. The actual IR values obtained are 
plotted in Fig. 6 along with those from Experiment 3. 
DISCUSSION 
Statistical Methods.--In most experimentation with infectious processes in 
animals, wide variation is a  rule rather than an exception. Thus, it becomes 
important to have some guide to the significance of the differences observed 
between control and  experimental groups, particularly when the number of 
animals in each group is small. Calculations of P  have provided that guide. In 
groups  in  which  survivorship  deprives  the  experiment of data,  or  in  which 
e The data for the 8 week period had to be disregarded since the disparity of behavior o[ 
the two groups of five mice, comprising the family of ten animals, was sufficient to compromise 
the findings. C. A. WILLIAMS, JR., AND R. J. DUBOS  997 
extreme high values would tend to exaggerate the efficacy of a protective agent, 
the calculation of mean cumulative average (MCA)  and index of resistance (IR) 
constitute an attempt to reduce the group response to a justifiable single term. 
From  the  experiments reported  certain  trends  in  these  quantities  become 
apparent.  As  the  mean  survival  time  (4)  of  the  control  group  is  increased, 
variability of individual response increases, hence the probability (P) that the 
observed difference between two means could occur by chance. However, the 
index of resistance also increases, indicating a  more pronounced difference.  For 
example, the FI-P vaccinated group in Table I  A  shows P  =  0.04,  which  is 
acceptable considering the small actual difference between the means. In Table 
II A a  similarly vaccinated group shows P  =  0.25, an unacceptable level, yet 
the IR in Table IIB derived from these data is higher than the IR in Table I B, 
hence a greater detectable difference. These observations apply similarly to the 
FI-S vaccinated groups, although P  increases much less drastically and does 
not attain an unacceptable level. From these observations, it is readily apparent 
that the subfraction FI-S is the most effective preparation. A single injection of 
a maximum dose of 0.05 nag. per mouse (cf. Table II B) was sufficient to increase 
the mean cumulative average survival time approximately 50 per cent. 
For evaluations of the  efficacy of treatment  the  IR  is the  quantity  most 
heavily leaned upon. A high confidence level is desirable, of course, and in the 
case  of  the  most  promising  fractions  this  was  consistently  90  per  cent  or 
better  (P <  0.1) and generally above 95 per cent (P <  0.05). 
Preparation of Methanol Extract.---One among many preliminary experiments 
deserves mention at this point. The relationship between the antigone m~tkylique 
of N~gre and Boquet (4), which was originally obtained by extraction of tubercle 
bacilli by methanol at 37 °, and methanol extract (ME), extracted by Weiss and 
Dubos (7) at 55 °, was of some concern. Both were capable of bestowing some 
protection on experimental animals, but the relative activities on a weight for 
weight basis in the same species of animal were not known. Since such informa- 
tion would have a  bearing on the preparation of active fractions of ME,  the 
fractional extracts of H37Rv, ME-40  °, and ME-60 °, were compared in a mouse 
protection testy They were found to be roughly equivalent, though inferior to a 
ME-60  ° preparation derived from BCG  (Phipps).  Since  ME-60  ° represented 
but  a  quarter  of  the  total  activity  extractable  by  methanol,  the  complete 
methanol extract was settled upon as a  starting material. 
The preparation  of the  materials has been described. With them were also tested an 
ME-60  ° from BCG (Phipps) and  an F  I  fraction from ME-40  ° (H37Rv). Groups of ten 
female mice were vaccinated with 2 nag. ME-60  °, 3 rag. ME-40  °, 3 rag. F I  (ME-40°), and 
1 rag. of ME-60  ° (BCG). Thirty-one days after vaccination the mice were challenged intra- 
venously with 0.1 ml. of a dispersed growth culture of VaU~e (MV) grown 14 days in tween- 
albumin medium. The controls showed a mean cumulative average survival time of about 
16, the vaccinated groups about 19.5; thus, an IR =  1.2. Only F I (ME-40  °) displayed any 
activity  at one-third the dose mentioned above. 998  METHANOL EXTRACTS  OF TUBERCLE  BACILLI.  I 
Mechanisms.--The question of mechanisms of resistance must be raised in 
discussing the effect of mixing F II and F I into the same vaccine. It is seen that 
the activity of F  I  is enhanced well beyond what would be expected from the 
independent contribution of F  II to the level of resistance if the effect of the 
admixture were a mere summation. While F  I  alone has no value in a dose of 
0.1 mg. per mouse, 0.05  rag. administered with an equal amount of F  II has 
considerably more effect on resistance than an equal amount of FI-S. FI-S is 
ten times more active than F I alone on a weight for weight basis. These findings 
are certainly reminiscent of adjuvant-antigen systems, and the fact that F II is 
a wax-like material would not make the relationship impossible. White,  with 
Bernstock, Johns, and Lederer  (19),  has demonstrated wax-D  from H37Rv 
capable of acting as adjuvant for antibody production, and with Marshall (20) 
for  allergic  encephalomyelitis.  Wax-D  is  a  chloroform-soluble,  methanol- 
insoluble glycolipid prepared according to Aebi, Asselineau, and Lederer (21). 
Freund and Stone (22), however, have recently published results of an excellent 
series of experiments which demonstrate that ten times more wax-D is needed 
than whole killed tubercle bacilli to induce allergic encephalomyelitis in mice 
and aspermatogenesis in guinea pigs. However, when either F I or F II was sub- 
stituted for mycobacteria as adjuvants to elicit delayed hypersensitivity to 
picryl chloride, according to Chase (23), these substances proved to be ineffec- 
tive in this system (24). 
It must be remembered, on the other hand, that the whole tubercle bacillus 
is a rich packet of biological activities, all theoretically residing in substances 
capable of chemical definition. Combined in fractions, or associated in complex 
in their natural state, or recombined in test tubes, it is reasonable to suppose 
that  the  activities of such  substances,  revealed by suitable  experiments  in 
suitable animals, could be complementary, supplementary, masked, antagonis- 
tic, inhibitory, or combinations of these. For this reason, it should not be sur- 
prising that purification of a  substance with protective activity from tubercle 
bacilli should effect no apparent increase in specific  activity over the whole 
killed tubercle bacilli. The material may have been separated from its natural 
adjuvant or other synergistic agent. Either F I or F II could be an example of 
this phenomenon. Nor should a potentiation of activity cause surprise, when it 
need only be postulated that the material in the course of its purification was 
separated from competitive or inhibiting substances, or that it was released 
from a complex in which it is but partially free to manifest its activity. FI-S or 
FI-CS might illustrate such a situation. 
Such might also be the fate of the adjuvant activity displayed by wax-D as 
employed by Freund  and  Stone  (22).  Another possibility suggested by  the 
experiments of these authors is that fragments of bacillary bodies may account 
for some of the biological activities of chemical fractions of tubercle bacilli. It is 
certainly true  that  the detection of such contaminants is difficult and  that C. A. V/ILLIAMS, ~R.,  AND R. J. DUBOS  999 
measures taken by other authors to assure their absence are not particularly 
convincing. This matter will be taken up in more detail in a  later report  (24). 
Prolongation of survival  time  in  animals vaccinated with killed tubercle 
bacilli, or even diminished numbers of viable bacteria in their various organs, 
cannot be attributed to any one known immune or non-lmmune mechanism 
of  resistance.  Furthermore,  no  immune  mechanism  of  which  the  bacillary 
component or of which the host component is detectable, has ever been con- 
clusively implicated in resistance to tuberculosis, experimental or  otherwise. 
The possible exception to this is the recent work with macrophages in  vitro, 
reported by Fong, Schneider, and Elberg (25, 26), demonstrating the presence 
in the serum of vaccinated animals of a substance which enhances the survival 
of "immune" macrophages infected with tubercle bacilli. This substance, how- 
ever, is not specifically evoked by tubercle bacilli. 
Some of the points discussed in the preceding paragraphs are pertinent to the 
interpretation of the experiments recorded in Tables III and IV, and repre- 
sented graphically in Fig. 6. The rather high level of resistance to both tuber- 
culosis and staphylococcus infection apparent 2 weeks after vaccination brings 
up the question of specificity and whether a so called immune mechanism can 
be imagined. If so, are we dealing with a protective antigen common to myco- 
bacteria and staphylococci? Evidence for the existence of common antigenic 
substances  has  been  presented  by  Lagercrantz  (27)  using  passive  hemag- 
glutination tests; but whether or not other microorganisms have these anti- 
gens, or whether they have anything to do with resistance can be answered only 
by  immunological  information  more  sophisticated  than  survival  times  of 
vaccinated  animals.  Some  bacterial  lipopolysaccharides  increase  resistance 
against a variety of infections including staphylococcus and tuberculosis (28), 
M ycobacterium fortuilum (29), and Salmonella typhosa, Escherichia coli, Pseudo- 
monas aeruginosa and Proteus vulgaris (30, 31) ; and although a classical immu- 
nological interpretation cannot be ruled out, none very convincing have been 
shown to date. 
In nearly all of these "broad specificity" effects, however, there is a marked 
fall-off after about 3 weeks. Data reported by Dubos and Schaedler (14) indicate 
that even vaccination with living BCG produces by 2 weeks a peak resistance 
to challenge with Mycobacteriumfortuitum  (Penso) but that the level of resist- 
ance had fallen off noticeably by 25 days post vaccination. In the case of staphy- 
lococcus  (Giorgio)  infection of mice vaccinated with killed BCG,  this lower 
level of resistance endures at least 10 weeks (14),  which lends support to the 
findings in Table IV that mice still show increased resistance to staphylococcus 
12 weeks after vaccination with F I. 
Hypothesis.--Fig.  7  summarizes  diagrammatically  an  hypothesis  which 
could account for the results of Experiments 3 and 4, and which could serve as 
a useful model upon which to design further experiments. The bimodal curve of I000  METHANOL EXTRACTS OF TUBERCLE BACILLI.  I 
resistance  to  experimental  tuberculosis  strongly  suggests  that  at  least  two 
independent and possibly supplementary mechanisms are involved. One effect, 
exhibiting broad specificity, or broad spectrum resistance, appears quite soon 
after vaccination, reaches a maximum between 2 and 3 weeks and then declines. 
A  second  increase  in  resistance  to  tuberculosis  is  provided perhaps  by  the 
stimulation  of a  more specific and  longer sustained  mechanism.  The period 
during which the animals are not protected, occurring sometime between 3 and 
5 weeks, represents the failure of these two effects to overlap in time with suffi- 
cient combined influence to afford a significant prolongation of survival. 
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FIG. 7. Hypothetical resolution of the discontinuous pattern of resistance to tuberculosis 
provided by vaccination with F I. 
This low resistance interval cannot be rigidly defined with either respect to 
time of appearance or duration. Indeed, it may not appear at all if one were to 
employ complex vaccines,  such  as  whole killed  tubercle bacilli  or  complete 
methanol extract, in which there may be many biologically active substances. 
And theoretically, if purified materials were used in large enough quantities, 
the stimuli to both mechanisms would be such as to provide the overlap of 
effects necessary to assure continuous elevation of resistance. 
Experiments are in progress to distinguish these effects and to identify the 
subfraction of F I responsible for each. 
Tuberculosis a~  Immunology.--Generally  speaking,  tuberculosis  is  a  poor 
tool for the investigation of some principles of immunology pertinent to this 
discussion. If challenge doses intended to insure a short survival time are used, 
some immune mechanisms of importance at the time of challenge may be over- 
whelmed. At best one could say that it might not have contributed to resist- 
ance; at worst it would pass unnoticed. Were the challenge dose low enough C. A. WILLIAMS, JR., AND R. J. DUBOS  I001 
that all mechanisms of defense at the time of infection might be thought to 
contribute toward the increased survival time of the animal,  the immune or 
resistant state, i.e. that condition possibly altered by vaccination, would be all 
but impossible to evaluate. Survival time has usually been extended well beyond 
that necessary for the animal  to have acquired a  certain immune resistance 
from the challenge  itself,  and though this may be facilitated by vaccination it 
may not involve the same processes and mechanisms operative in the first hours 
of the infection.  Furthermore  in  the case of a  slowly progressive or  chronic 
disease,  there is the possibility of a quite different general host physiology and 
pattern of resistance to infections. 
Thus, at the present state of knowledge, experimentation with vaccine prep- 
arations against tuberculosis in animals is probably most profitably reduced to 
the empirical  evaluation  of their  effectiveness.  Findings  of more  theoretical 
significance  might best be transferred to more easily manipulated systems for 
further study or extension.  As for the effectiveness  of a  vaccine preparation, 
two criteria have been put forward by the proponents of BCG as minimum 
standards:  first,  survivorship  or  extended  survival  time  equivalent  to  that 
afforded by BCG, and second, long-lasting  protection. 
Pierce and  Dubos  (32)  have made  an  exhaustive study of  the  increased 
resistance in Rockefeller Swiss mice following vaccination with several strains 
and dosages of BCG. Analysis of their data for a group of these mice injected 
intravenously with approximately 106 viable units of BCG (Phipps), the most 
effective preparation employed by these authors, reveals an IR  =  1.43, or an 
increase of survival time by little more than 40 per cent. This is in the range of 
resistance provided by vaccination with 0.05  to 0.1  rag.  of FI-S.  IAvy and 
Conge  (33)  report experiments  using  Rockefeller Swiss mice in  which some 
groups vaccinated with living BCG achieved an IR  =  1.6 34 days post vaccina- 
tion. It must be mentioned in this regard, however, that BCG has been reported 
by Bloch and Segal (34) to increase survival time roughly threefold (IR =  2.8 
and 3.5) in CF-1 mice challenged  with H37Rv 2 to 3 weeks after vaccination. 
These  authors,  comparing  vaccinated  and  control  median  survival  times, 
actually an unreliable value in small samples,  report "vaccination indexes" of 
3.7 and 4.8 (i.e. greater than fourfold increase in survival time) respectively for 
the groups referred to. Bloch is of the opinion, however, that the efficacy of BCG, 
and presumably therefore, of any vaccine, varies greatly with the strain of mice 
employed,  s 
From the results of experiments with FI-S presented above, nothing can be 
said about the duration of this effect except that the level of resistance bestowed 
s In a  personal communication, Dr.  Bloch states that another worker was able to elicit 
only minor increases of resistance in a not highly inbred strain of Swiss mice using Dr. Bloch's 
strain of BCG, which is derived from the Copenhagen strain; but that later with CF-1 mice 
provided by Dr.  Bloch was able to obtain results similar to  those of Dr.  Bloch. 1002  METHANOL EXTRACTS OF TUBERCLE BACILLI.  I 
on this strain of mice by the parent fraction, F  I, remains undiminished at 12 
weeks post vaccination. The advantage of FI-S or unpurified F  I  mixed with 
F  II is that these preparations are non-toxic, non-allergic (i.e.  will not elicit 
tuberculin sensitivity in guinea pigs), and non-infectious (24). It is strongly felt 
that these characteristics should be added to the criteria of an acceptable vac- 
cine against tuberculosis. 
The authors wish to express their gratitude to Miss A. Hafleigh for her assistance in the 
analysis of the data and the preparation of the tables. 
SUMMARY 
Fractionation  procedures  yielding  partially  purified  vaccine  preparations 
from a 60°C. methanol extract of tubercle bacilli have been described. Some of 
the preparations have the characteristics of lipopolysaccharides. Certain ones 
have  been  found  capable  of  increasing  resistance  to  experimental  tuber- 
culosis in albino mice of the Rockefeller Swiss strain. The levels of resistance 
elicited by these preparations are equivalent to those following vaccination with 
BCG (Phipps) in this strain of mice as reported by other authors. The admixture 
of two of the crude fractions in amounts as small as 0.05 rag. each per dose 
per mouse affords an even greater increase in resistance. Neither of these sub- 
stances alone in larger doses can approach this degree of efficacy in mouse pro- 
tection experiments. 
The protective activity appears to involve the stimulation of two supple- 
mentary mechanisms, one providing a peak resistance between 1 and 3 weeks 
post vaccination but falling off to a lower level thereafter, the other not respond- 
ing fully until approximately 6 weeks but continuing undiminished through a 
12 week post-vaccination period. The first of these peaks corresponds to an 
increase  in  resistance  against  staphylococci as  well  as  tubercle  bacilli.  The 
possibility  that  the  term  "broad  specificity," rather  than  "non-specificity," 
might  best  describe  this  phenomenon  permits  the  implication  of  classical 
immune mechanisms. 
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